These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32565739)

  • 1. DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups.
    Tian Z; Meng L; Long X; Diao T; Hu M; Wang M; Liu M; Wang J
    Cancer Cell Int; 2020; 20():255. PubMed ID: 32565739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation-based classification and identification of renal cell carcinoma prognosis-subgroups.
    Chen W; Zhuang J; Wang PP; Jiang J; Lin C; Zeng P; Liang Y; Zhang X; Dai Y; Diao H
    Cancer Cell Int; 2019; 19():185. PubMed ID: 31346320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.
    Li C; Ke J; Liu J; Su J
    J Cell Biochem; 2020 Mar; 121(3):2713-2724. PubMed ID: 31680300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer.
    Zhang C; Shen K; Zheng Y; Qi F; Luo J
    Cancer Med; 2020 Jan; 9(2):768-782. PubMed ID: 31794632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of prognosis-related molecular subgroups based on DNA methylation in pancreatic cancer.
    Yin X; Kong L; Liu P
    Clin Epigenetics; 2021 May; 13(1):109. PubMed ID: 33980289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation data-based molecular subtype classification and prediction in patients with gastric cancer.
    Lian Q; Wang B; Fan L; Sun J; Wang G; Zhang J
    Cancer Cell Int; 2020; 20():349. PubMed ID: 32742196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
    Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S
    Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer.
    Bian J; Long JY; Yang X; Yang XB; Xu YY; Lu X; Sang XT; Zhao HT
    World J Gastroenterol; 2020 Nov; 26(41):6414-6430. PubMed ID: 33244202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific Glioma Prognostic Subtype Distinctions Based on DNA Methylation Patterns.
    Chen X; Zhao C; Zhao Z; Wang H; Fang Z
    Front Genet; 2019; 10():786. PubMed ID: 31572431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients.
    Yang C; Zhang Y; Xu X; Li W
    Aging (Albany NY); 2019 Dec; 11(24):11880-11892. PubMed ID: 31852837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients.
    Cai H; Chen H; Huang Q; Zhu JM; Ke ZB; Lin YZ; Zheng QS; Wei Y; Xu N; Xue XY
    Pathol Oncol Res; 2021; 27():1609941. PubMed ID: 34776794
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA.
    Oh TJ; Lim E; Bang BR; Lee JJ; Na YG; Shin JH; Lim JS; Song KH; An S
    BMC Cancer; 2022 Nov; 22(1):1195. PubMed ID: 36403035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis.
    Liu L; Hu J; Wang Y; Sun T; Zhou X; Li X; Ma F
    Aging (Albany NY); 2020 Jun; 12(12):11967-11989. PubMed ID: 32570217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Analysis of Differentially Expressed DNA Damage Repair Genes in Bladder Cancer.
    Yang Y; Yu J; Xiong Y; Xiao J; Dai D; Zhang F
    Pathol Oncol Res; 2022; 28():1610267. PubMed ID: 35685866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation data-based prognosis-subtype distinctions in patients with esophageal carcinoma by bioinformatic studies.
    Chen H; Qin Q; Xu Z; Chen T; Yao X; Xu B; Sun X
    J Cell Physiol; 2021 Mar; 236(3):2126-2138. PubMed ID: 32830322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.
    Shi S; Xu M; Xi Y
    Aging (Albany NY); 2020 Nov; 12(23):23917-23930. PubMed ID: 33237038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer.
    Wang W; Zhang X; Jiang S; Xu P; Chen K; Li K; Wang F; Le X; Zhang K
    Front Immunol; 2023; 14():1187286. PubMed ID: 37691944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Gene Prognostic Signature Based on Differential DNA Methylation in Breast Cancer.
    Zhu C; Zhang S; Liu D; Wang Q; Yang N; Zheng Z; Wu Q; Zhou Y
    Front Genet; 2021; 12():742578. PubMed ID: 34956313
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytoskeleton regulator RNA expression on cancer-associated fibroblasts is associated with prognosis and immunotherapy response in bladder cancer.
    Wu Y; Xu Y; He S; Li Y; Feng N; Fan J; Gong Y; Li X; Zhou L
    Heliyon; 2023 Mar; 9(3):e13707. PubMed ID: 36873531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.